Full text is available at the source.
Abstract
PRAT thickness was assessed under GLP-1RA-based therapy in chronic kidney disease (CKD) patients.
- Perirenal adipose tissue (PRAT) surrounds the kidney and may play a role in the progression of chronic kidney disease (CKD).
- SGLT2 inhibitors have been linked to reductions in PRAT, but this has not been quantified with GLP-1 receptor agonist therapy.
- Ultrasound was used to measure PRAT thickness in the study participants.
- The research aimed to determine if changes in PRAT thickness were associated with weight loss.
Simplified